Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat

Journal of Neuroscience

Volumn 26, Issue 14, 2006, Pages 3855-3863

  Meloni, Edward G ^a   Gerety, Lyle P ^a   Knoll, Allison T ^a   Cohen, Bruce M ^a   Carlezon Jr , William A ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Anxiety; BNST; CRH; D1; SCH 23390; Startle

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; FLUOROGOLD; TRACER; TYROSINE 3 MONOOXYGENASE;

AFFECT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BRAIN NERVE CELL; BRAIN REGION; CELL NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; HYPERACTIVITY; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; MALE; MOOD; NONHUMAN; NORADRENERGIC SYSTEM; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; STARTLE REFLEX; STRESS; STRIA TERMINALIS; TRANQUILIZING ACTIVITY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; MALE; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STARTLE REACTION;

EID: 33645564501     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4957-05.2006     Document Type: Article

References (70)

1. Alheid G, de Olmos JS, Beltramino CA (1995) Amygdala and extended amygdala. In: The rat nervous system (Paxinos G, ed), pp 443-494. New York: Academic.
2. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB (1999) The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160:1-12.
3. Armstrong DM, Ross CA, Pickel VM, Joh TH, Reis DJ (1982) Distribution of dopamine-, noradrenaline-, and adrenaline-containing cell bodies in the rat medulla oblongata: demonstrated by the immunocytochemical localization of catecholamine biosynthetic enzymes. J Comp Neurol 212:173-187.
4. Birnbaum SG, Davis M (1998) Modulation of the acoustic startle reflex by infusion of corticotropin-releasing hormone into the nucleus reticularis pontis caudalis. Brain Res 782:318-323.
5. Bischoff S, Heinrich M, Sonntag JM, Krauss J (1986) The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors. Eur J Pharmacol 129:367-370.
6. Bowers LK, Swisher CB, Behbehani MM (2003) Membrane and synaptic effects of corticotropin-releasing factor on periaqueductal gray neurons of the rat. Brain Res 981:52-57.
7. Boyer P (2000) Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl 102:24-29.
8. Cassell MD, Gray TS, Kiss JZ (1986) Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological and immunocytochemical study. J Comp Neurol 246:478-499.
9. Chalmers DT, Lovenberg TW, De Souza EB (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350.
10. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, Nemeroff CB (1986) Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6:2908-2914.
11. Conti LH, Murry JD, Ruiz MA, Printz MP (2002) Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology (Berl) 161:296-303.
12. Dado RJ, Burstein R, Cliffer KD, Giesler Jr GJ (1990) Evidence that Fluoro-Gold can be transported avidly through fibers of passage. Brain Res 533:329-333.
13. Davis M, Walker DL, Lee Y (1997) Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philos Trans R Soc Lond B Biol Sci 352:1675-1687.
14. de la Mora MP, Cárdenas-Cachón L, Vázquez-Garcia M, Crespo-Ramirez M, Jacobsen K, Höistad M, Agnati L, Fuxe K (2005) Anxiolytic effects of intra-amygdaloid injection of the D1 antagonist SCH23390 in the rat. Neurosci Lett 377:101-105.
15. DeSouza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ (1985) Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci 5:3189-3203.
16. Dunn AJ, Berridge CW (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses. Brain Res Brain Res Rev 15:71-100.
17. Eliava M, Yilmazer-Hanke D, Asan E (2003) Interrelations between monoaminergic afferents and corticotropin-releasing factor-immunoreactive neurons in the rat central amygdaloid nucleus: ultrastructural evidence for dopaminergic control of amygdaloid stress systems. Histochem Cell Biol 120:183-197.
18. Erb S, Stewart J (1999) A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stressinduced reinstatement of cocaine seeking. J Neurosci 19:1-6.
19. Finlay JM, Zigmond MJ, Abercrombie ED (1995) Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 64:619-628.
20. Flores JA, Banoua FE, Galan-Rodriguez B, Fernandez-Espejo E (2004) Opiate anti-nociception is attenuated following lesions of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 110:205-214.
21. Frankland PW, Ralph MR (1995) Circadian modulation in the rat acoustic startle circuit. Behav Neurosci 109:43-48.
22. Freedman LJ, Cassell MD (1994) Distribution of dopaminergic fibers in the central division of the extended amygdala of the rat. Brain Res 633:243-252.
23. Gold PW, Chrousos GP (2002) Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 7:254-275.
24. Gray TS, Magnuson DJ (1992) Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13:451-460.
25. Hasue RH, Shammah-Lagnado SJ (2002) Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. J Comp Neurol 454:15-33.
26. Heim C, Nemeroff CB (1999) The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol Psychiatry 46:1509-1522.
27. Herbert H (1992) Evidence for projections from medullary nuclei onto serotonergic and dopaminergic neurons in the midbrain dorsal raphe nucleus of the rat. Cell Tissue Res 270:149-156.
28. Hokfelt T, Martensson R, Bjorklund A, Kleinau S, Goldstein M (1984) Distribution maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. In: Handbook of chemical neuroanatomy. Classical transmitters in the CNS, part I (Bjorklund A, Hokfelt T, eds), pp 277-379. Amsterdam: Elsevier Science.
29. Hornby PJ, Piekut DT (1989) Opiocortin and catecholamine input to CRF-immunoreactive neurons in rat forebrain. Peptides 10:1139-1146.
30. Iorio LC, Barnett A, Leitz FM, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine anti-psychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462-468.
31. Jasnow AM, Davis M, Huhman KL (2004) Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral response to social defeat. Behav Neurosci 118:1052-1061.
32. Jones DNC, Kortekaas R, Slade PD, Middlemiss DN, Hagan JJ (1998) The behavioral effects of corticotropin-releasing factor-related peptides in rats. Psychopharmacology (Berl) 138:124-132.
33. Ju G, Han Z (1989) Coexistence of corticotropin releasing factor and neurotensin within oval nucleus in the bed nuclei of the stria terminalis. Neurosci Lett 99:246-250.
34. Ju G, Swanson LW, Simerly RB (1989) Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture. J Comp Neurol 280:603-621.
35. Kessler RC, Chiu WT, Demler O, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:617-627.
36. Koob GF (1999) Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 46:1167-1180.
37. Lamont EW, Kokkinidis L (1998) Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res 795:128-136.
38. Lee Y, Davis M (1997) Role of the hippocampus, bed nucleus of the stria terminalis and amygdala in the excitatory effect of corticotropin releasing hormone (CRH) on the acoustic startle reflex. J Neurosci 17:6434-6446.
39. Lee Y, Schulkin J, Davis M (1994) Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF). Brain Res 666:93-98.
40. Lee Y, Lopez DE, Meloni EG, Davis M (1996) A primary acoustic startle circuit: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis. J Neurosci 16:3775-3789.
41. Liang KC, Melia KR, Campeau S, Falls WA, Miserendino MJD, Davis M (1992a) Lesions of the central nucleus of the amygdala, but not of the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin releasing factor on the acoustic startle reflex. J Neurosci 12:2313-2320.
42. Liang KC, Melia KR, Miserendino MJD, Falls WA, Campeau S, Davis M (1992b) Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J Neurosci 12:2303-2312.
43. McEwen BS (2000) Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 22:108-124.
44. Merchenthaler I (1984) Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 5:53-69.
45. Mitchell AJ (1998) The role of corticotropin releasing factor in depressive illness: a critical review. Neurosci Biobehav Rev 22:635-651.
46. Moga MM, Saper CB, Gray TS (1989) Bed nucleus of the stria terminalis: cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat. J Comp Neurol 283:315-332.
47. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, Ed 3. New York: Academic.
48. Phelix CF, Liposits Z, Paull WK (1992) Monoamine innervation of bed nucleus of stria terminalis: an electron microscopic investigation. Brain Res Bull 28:949-965.
49. Phelix CF, Liposits Z, Paull WK (1994) Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res Bull 33:109-119.
50. Rosen JB, Hitchcock JM, Sananes CB, Miserendino MJD, Davis M (1991) A direct projection from the central nucleus of the amygdala to the acoustic startle pathway: anterograde and retrograde tracing studies. Behav Neurosci 105:817-825.
51. Sakanaka M, Shibasaki T, Lederis K (1987) Corticotropin-releasing factorlike immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J Comp Neurol 260:256-298.
52. Savasta M, Dubois A, Scatton B (1986) Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390. Brain Res 375:291-301.
53. Schmued LC, Fallon JH (1986) Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties. Brain Res 377:147-154.
54. Schulkin J, McEwen BS, Gold PW (1994) Allostasis, amygdala, and anticipitory angst. Neurosci Biobehav Rev 18:385-396.
55. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Tingley FD, Winston EN, Chen YL, Heym J (1996) CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 93:10477-10482.
56. Scibilia RJ, Lachowicz JE, Kilts CD (1992) Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 11:146-154.
57. Servatius RJ, Beck KD, Moldow RL, Salameh G, Tumminello TP, Short KR (2005) A stress-induced anxious state in male rats: corticotropin-releasing hormone induces persistent changes in associative learning and startle reactivity. Biol Psychiatry 57:865-872.
58. Smagin GN, Heinrichs SC, Dunn AJ (2001) The role of CRH in behavioral responses to stress. Peptides 22:713-724.
59. Spedding M, Neau I, Harsing L (2003) Brain plasticity and pathology in psychiatric disease: sites of action for potential therapy. Curr Opin Pharmacol 3:1-8.
60. Steckler T, Holsboer F (1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46:1480-1508.
61. Swerdlow NR, Geyer MA, Vale WW, Koob GF (1986) Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berl) 88:147-152.
62. Toufexis DJ, Davis C, Hammond A, Davis M (2004) Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J Neurosci 24:10280-10287.
63. Van Pett K, Viau V, Bittencourt JC, Chan RKW, Li H-Y, Arias C, Prins GS, Perrin MH, Vale W, Sawchenko PE (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212.
64. Vermetten E, Bremner JD (2002a) Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder. Depress Anxiety 16:14-38.
65. Vermetten E, Bremner JD (2002b) Circuits and systems in stress. I. Preclinical studies. Depress Anxiety 15:126-147.
66. Walker DL, Toufexis DJ, Davis M (2003) Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463:199-216.
67. Weber M, Richardson R (2001) Centrally administered corticotropin- releasing hormone and peripheral injections of strychnine hydrochloride potentiate the acoustic startle response in preweanling rats. Behav Neurosci 115:1273-1282.
68. Weller KL, Smith DA (1982) Afferent connections to the bed nucleus of the stria terminalis. Brain Res 232:255-270.
69. Wessendorf M (1991) Fluoro-Gold: composition, and mechanism of uptake. Brain Res 553:135-148.
70. Wynn PC, Hauger RL, Holmes MC, Millan MA, Catt KJ, Aguilera G (1984) Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy. Peptides 5:1077-1084.